Adam Mendelsohn
Principal executive officer pay for Adam Mendelsohn, by year and company, from pay-versus-performance disclosure. Every figure links to its source on the company page.
Vivani Medical, Inc. (VANI) FY2022–FY2025
Aligned: paid up as stock roseCAP $292,957→$856,945 while $100 invested went $20.52→$144.76
| Fiscal year | SCT total | Comp actually paid |
|---|---|---|
| FY2022 | $312,014 | $292,957 |
| FY2023 | $1.0M | $954,818 |
| FY2024 | $1.1M | $915,162 |
| FY2025 | $877,580 | $856,945 |
The company's "$100 invested" index ran $20.52 at FY2022 → $144.76 by FY2025 — an annualized return of 91.8%.
Track record
1 measurable tenure in the pay-versus-performance disclosure window. Best annualized TSR: 91.8%/yr at VANI ( FY2022–FY2025). See the CEO track-record ranking for context.